Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma: a systematic reviewAbdel-RahmanEfficacy & safety of different pembrolizumab dose/schedules in treatment of NSCLC & melanoma (vol 8, pg 1383, 2016)

Abdel-Rahman Omar

首页> 外文期刊>Immunotherapy >Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma: a systematic reviewAbdel-RahmanEfficacy & safety of different pembrolizumab dose/schedules in treatment of NSCLC & melanoma (vol 8, pg 1383, 2016)

【24h】

Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma: a systematic reviewAbdel-RahmanEfficacy & safety of different pembrolizumab dose/schedules in treatment of NSCLC & melanoma (vol 8, pg 1383, 2016)

机译：评估不同蛋白酶剂量/调度治疗非小细胞肺癌和黑色素瘤的疗效和安全性的评估：一种系统评测DEL-RAHMAFCACY和SAFED的NSCLC＆黑素瘤的不同蛋白酶剂量/时间表（VOL 8，PG 1383， 2016）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Immunotherapy》 |2017年第4期|共1页
作者
Abdel-Rahman Omar;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类一般性问题;
关键词

相似文献

外文文献
中文文献
专利

1. Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma: a systematic reviewAbdel-RahmanEfficacy & safety of different pembrolizumab dose/schedules in treatment of NSCLC & melanoma (vol 8, pg 1383, 2016) [J] . Abdel-Rahman Omar Immunotherapy . 2017,第4期

机译：评估不同蛋白酶剂量/调度治疗非小细胞肺癌和黑色素瘤的疗效和安全性的评估：一种系统评测DEL-RAHMAFCACY和SAFED的NSCLC＆黑素瘤的不同蛋白酶剂量/时间表（VOL 8，PG 1383， 2016）
2. P3.02c-030 Use of a 200-Mg Fixed Dose of Pembrolizumab for the Treatment of Advanced Non–Small Cell Lung Cancer (NSCLC) [J] . Edward Garon, Martin Reck, Delvys Rodríguez-Abreu, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P3.02C-030使用200mg固定剂量的Pembrolizumab用于治疗先进的非小细胞肺癌（NSCLC）
3. P3.02c-030 Use of a 200-Mg Fixed Dose of Pembrolizumab for the Treatment of Advanced Non–Small Cell Lung Cancer (NSCLC) [J] . Edward Garon, Martin Reck, Delvys Rodríguez-Abreu, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P3.02C-030使用200mg固定剂量的Pembrolizumab用于治疗先进的非小细胞肺癌（NSCLC）
4. Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models [C] . Kishore Rollakanti, Sanjay Anand, Edward V. Maytin Optical methods for tumor treatment and detection: mechanisms and techniques in photodynamic therapy XXIV . 2015

机译：光动力疗法前的局部骨化三醇可增强非黑色素瘤皮肤癌小鼠模型的治疗功效
5. Inhalable nanoparticles in lung cancer treatment; efficacy, safety, distribution and nanoparticle-macrophage interactions. [D] . Al-Hallak, Mhd Kamal. 2012

机译：可吸入性纳米颗粒在肺癌治疗中的作用；功效，安全性，分布以及纳米颗粒与巨噬细胞的相互作用。
6. Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment [O] . Erik S. Anderson, Michael A. Postow, Jedd D. Wolchok, 2017

机译：立体定向放射治疗和同时进行的派姆单抗治疗的黑色素瘤脑转移表现出明显的消退；联合治疗的有效性和安全性
7. A Phase I, open-label, dose escalation study of MGA271 in combination with pembrolizumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck, or squamous cell non-small cell lung cancer [O] . Jan Baughman, Deryk Loo, Francine Chen, 2015

机译：MGA271联合派姆单抗在B7-H3表达黑素瘤，头颈部鳞状细胞癌或鳞状细胞非小细胞肺癌患者中进行的I期开放标签剂量递增研究

Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma: a systematic reviewAbdel-RahmanEfficacy & safety of different pembrolizumab dose/schedules in treatment of NSCLC & melanoma (vol 8, pg 1383, 2016)

著录项

相似文献

相关主题

期刊订阅